Zika virus hijacks a key protein implicated in brain development for its own replication. Researchers led by Associate Professor Priya Shah at the University of California, Davis (CA, USA), have ...

Though Gilead Sciences made waves last June with a landmark FDA approval for its twice-yearly HIV preventive Yeztugo (lenacapavir), the first-in-class drug had previously been used as a long-acting ...

Nipah virus does not just infect the body, it disrupts immune defences at multiple levels, suppressing early antiviral responses and triggering harmful inflammation.

How does the body react after contracting the deadly NiV? Expert explains how the Nipah virus attacks the brain, leading to ...

The mosquito-borne Zika virus is known for causing microcephaly, a birth defect in which abnormal brain development results in a smaller-than-expected head. A new study published Jan. 13 in mBio shows ...

The mosquito-borne Zika virus hijacks a host protein called ANKLE2 to support its own reproduction. ANKLE2 is involved in brain development in the fetus and because Zika can cross the placenta and ...

A new study shows that the body’s early immune response, not the virus itself, often determines how severe a rhinovirus cold ...

Nipah virus outbreak in India has prompted screenings across Asia. While one nurse in Kolkata has been discharged, ...

Researchers have discovered that virus-like nanoparticles can promote the multicellular organization and reproduction of host bacteria. These particles, which are evolutionarily related to phages ...

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...